Anti-CD13 (22A5)

Anti-CD13 (22A5), Recombinant, IgG4-S228P kappa, Host: Human
Artikelnummer
ABAAb00858-13.12
Verpackungseinheit
200 μg
Hersteller
Absolute Antibody

Verfügbarkeit: wird geladen...
Preis wird geladen...
CloneID: 22A5

Antigen Long Description: Female BALB/c mice were primed by intraperitoneal immunization with OC-containing cell suspensions from OCL tumors. Supernatants from growth-positive cultures were screened initially for antibody on acetone-fixed OCL tumor imprints using the indirect immunofluorescent techniques.

Buffer Composition: PBS with 0.02% Proclin 300.

Chimeric Use Statement: This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

Available Custom Conjugation Options: AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7

Uniprot Accession No.: P15144

Specificity Statement: This antibody is specific for CD13, with the same reactivity as MY7 and 15D6 antibodies

Application Notes (Clone): This antibody has been used for immunofluorescent staining of CD13 in human T cell lymphoma lines, observed by confocal fluorescence microscopy (Murray 1995). 22A5 may be useful for the diagnosis and immunophenotyping of leukaemia.
Mehr Informationen
Artikelnummer ABAAb00858-13.12
Hersteller Absolute Antibody
Hersteller Artikelnummer Ab00858-13.12
Verpackungseinheit 200 μg
Mengeneinheit STK
Reaktivität Human
Klonalität Recombinant
Methode Immunoprecipitation, Flow Cytometry, Immunohistochemistry
Isotyp IgG4-S228P kappa
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF) Download